Showing codes Q2 (Demonstration procedure/service) — Q3 (Live kidney donor surgery and related services)

Q2 - Demo procedure, service
Long description: Demonstration procedure/service
Code added date: 19920101.
Code effective date: 20170101.
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q2004 - Bladder calculi irrig sol
Long description: Irrigation solution for treatment of bladder calculi, for example renacidin, per 500 ml
Code added date: 20000701.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2009 - Fosphenytoin inj pe
Long description: Injection, fosphenytoin, 50 mg phenytoin equivalent
Code added date: 20000701.
Code effective date: 20200101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2017 - Teniposide, 50 mg
Long description: Injection, teniposide, 50 mg
Code added date: 20000701.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2026 - Radiesse injection
Long description: Injection, radiesse, 0.1 ml
Code added date: 20100701.
Code effective date: 20200101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2027 - Sculptra injection
Long description: Injection, sculptra, 0.1 ml
Code added date: 20100701.
Code effective date: 20140101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2028 - Inj, sculptra, 0.5mg
Long description: Injection, sculptra, 0.5 mg
Code added date: 20140101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2033 - Influenza vaccine, (flublok)
Long description: Influenza vaccine, recombinant hemagglutinin antigens, for intramuscular use (flublok)
Code added date: 20130701.
Code effective date: 20140101.
Pricing Indicator Code(s): 54 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2034 - Agriflu vaccine
Long description: Influenza virus vaccine, split virus, for intramuscular use (agriflu)
Code added date: 20120701.
Code effective date: 20140101.
Pricing Indicator Code(s): 54 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2035 - Afluria vacc, 3 yrs & >, im
Long description: Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)
Code added date: 20110101.
Code effective date: 20140101.
Pricing Indicator Code(s): 54 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2036 - Flulaval vacc, 3 yrs & >, im
Long description: Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)
Code added date: 20110101.
Code effective date: 20140101.
Pricing Indicator Code(s): 54 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2037 - Fluvirin vacc, 3 yrs & >, im
Long description: Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)
Code added date: 20110101.
Code effective date: 20140101.
Pricing Indicator Code(s): 54 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2038 - Fluzone vacc, 3 yrs & >, im
Long description: Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)
Code added date: 20110101.
Code effective date: 20140101.
Pricing Indicator Code(s): 54 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2039 - Influenza virus vaccine, nos
Long description: Influenza virus vaccine, not otherwise specified
Code added date: 20110101.
Code effective date: 20170101.
Pricing Indicator Code(s): 54 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2040 - Tisagenlecleucel car-pos t
Long description: Tisagenlecleucel, up to 250 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion
Code added date: 20180101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q2041 - Axicabtagene ciloleucel car+
Long description: Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Code added date: 20180401.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q2042 - Tisagenlecleucel car-pos t
Long description: Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Code added date: 20190101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q2043 - Sipuleucel-t auto cd54+
Long description: Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion
Code added date: 20110701.
Code effective date: 20110701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2045 - Human fibrinogen conc inj
Long description: Injection, human fibrinogen concentrate, 1 mg
Code added date: 20120701.
Code effective date: 20130101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q2046 - Aflibercept injection
Long description: Injection, aflibercept, 1 mg
Code added date: 20120701.
Code effective date: 20130101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q2047 - Peginesatide injection
Long description: Injection, peginesatide, 0.1 mg (for esrd on dialysis)
Code added date: 20120701.
Code effective date: 20130101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q2048 - Doxil injection
Long description: Injection, doxorubicin hydrochloride, liposomal, doxil, 10 mg
Code added date: 20120701.
Code effective date: 20130101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q2049 - Imported lipodox inj
Long description: Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg
Code added date: 20120701.
Code effective date: 20120701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q2050 - Doxorubicin inj 10mg
Long description: Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg
Code added date: 20130701.
Code effective date: 20130701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2051 - Zoldedronic acid 1mg
Long description: Injection, zoledronic acid, not otherwise specified, 1mg
Code added date: 20130701.
Code effective date: 20140101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q2052 - Home ivig, services/supplies
Long description: Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)
Code added date: 20140401.
Code effective date: 20230701.
Pricing Indicator Code(s): 57 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2053 - Brexucabtagene car pos t
Long description: Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Code added date: 20210401.
Code effective date: 20210401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q2054 - Lisocabtagene mara car pos t
Long description: Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Code added date: 20211001.
Code effective date: 20211001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q2055 - Idecabtagene vicleucel car
Long description: Idecabtagene vicleucel, up to 510 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Code added date: 20220101.
Code effective date: 20240404.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q2056 - Ciltacabtagene car-pos t
Long description: Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Code added date: 20221001.
Code effective date: 20221001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q3 - Live donor surgery/services
Long description: Live kidney donor surgery and related services
Code added date: 19950101.
Code effective date: 20030101.
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF